Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ZARMO MEDICAL CONSULTING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   9.1% 12.9% 10.8% 10.5% 9.7% 5.7% 17.4% 17.4%   Credit score (0-100)   28 19 22 22 24 39 9 9   Credit rating   BB BB BB BB BB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   48.6 64.2 19.1 127 308 432 0.0 0.0   EBITDA   48.6 64.2 19.1 127 308 231 0.0 0.0   EBIT   48.6 64.2 19.1 127 308 231 0.0 0.0   Pre-tax profit (PTP)   0.7 145.6 -78.9 93.4 301.2 214.5 0.0 0.0   Net earnings   0.7 136.8 -70.1 93.4 262.7 165.2 0.0 0.0   Pre-tax profit without non-rec. items   0.7 146 -78.9 93.4 301 214 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -91.7 45.1 -25.0 68.4 331 437 251 251   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   172 322 229 327 535 774 251 251   Net Debt   -172 -309 -229 -327 -465 -756 -251 -251     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   48.6 64.2 19.1 127 308 432 0.0 0.0   Gross profit growth   223.8% 32.0% -70.3% 568.8% 141.6% 40.1% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   172 322 229 327 535 774 251 251   Balance sheet change%   0.4% 86.6% -28.7% 42.4% 63.8% 44.6% -67.5% 0.0%   Added value   48.6 64.2 19.1 127.4 308.0 231.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 53.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.4% 51.1% 6.6% 43.9% 72.8% 35.5% 0.0% 0.0%   ROI %   0.0% 663.7% 84.5% 372.8% 156.9% 60.5% 0.0% 0.0%   ROE %   0.4% 125.8% -51.1% 62.7% 131.5% 43.0% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   -34.7% 14.0% -9.8% 20.9% 61.9% 56.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -354.3% -481.3% -1,203.6% -256.2% -150.9% -326.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.7 1.2 0.9 1.3 3.2 2.7 0.0 0.0   Current Ratio   0.7 1.2 0.9 1.3 3.2 2.7 0.0 0.0   Cash and cash equivalent   172.3 309.1 229.3 326.5 464.6 755.5 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -138.1 -78.0 -60.4 64.7 360.4 476.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   49 64 19 127 308 231 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   49 64 19 127 308 231 0 0   EBIT / employee   49 64 19 127 308 231 0 0   Net earnings / employee   1 137 -70 93 263 165 0 0